DrugPatentWatch Database Preview
Bausch And Lomb Company Profile
What is the competitive landscape for BAUSCH AND LOMB, and what generic alternatives to BAUSCH AND LOMB drugs are available?
There are twenty-seven US patents protecting BAUSCH AND LOMB drugs.
There are two hundred and twenty-nine patent family members on BAUSCH AND LOMB drugs in forty-two countries and forty-nine supplementary protection certificates in eleven countries.
Summary for Bausch And Lomb
| International Patents: | 229 |
| US Patents: | 27 |
| Tradenames: | 66 |
| Ingredients: | 54 |
| NDAs: | 77 |
| Patent Litigation for Bausch And Lomb: | See patent lawsuits for Bausch And Lomb |
Drugs and US Patents for Bausch And Lomb
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | VITRASE | hyaluronidase | INJECTABLE;INJECTION | 021640-001 | May 5, 2004 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Bausch And Lomb | NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC | bacitracin zinc; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 064064-001 | Oct 30, 1995 | AT | RX | No | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Bausch And Lomb | MINOXIDIL (FOR MEN) | minoxidil | SOLUTION;TOPICAL | 074643-001 | Apr 9, 1996 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Bausch And Lomb | LEVOBUNOLOL HYDROCHLORIDE | levobunolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 074307-001 | Mar 4, 1994 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Bausch And Lomb
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | LOTEMAX | loteprednol etabonate | GEL;OPHTHALMIC | 202872-001 | Sep 28, 2012 | 5,800,807 | ➤ Try a Free Trial |
| Bausch And Lomb | ZYLET | loteprednol etabonate; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050804-001 | Dec 14, 2004 | 5,747,061*PED | ➤ Try a Free Trial |
| Bausch And Lomb Inc | XIBROM | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 021664-001 | Mar 24, 2005 | 4,910,225 | ➤ Try a Free Trial |
| Bausch And Lomb | ALREX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020803-001 | Mar 9, 1998 | 4,996,335*PED | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.5% | ➤ Subscribe | 2012-10-19 |
| ➤ Subscribe | Ophthalmic Solution | 0.07% | ➤ Subscribe | 2013-07-26 |
| ➤ Subscribe | Ophthalmic Solution | 1.5% | ➤ Subscribe | 2013-09-09 |
Non-Orange Book US Patents for Bausch And Lomb
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,569,443 | Topical treatment or prevention of ocular infections | ➤ Try a Free Trial |
| 8,338,421 | Compositions and methods for reversing rebound hyperemia | ➤ Try a Free Trial |
| 8,283,350 | Compositions and methods for reducing capillary permeability | ➤ Try a Free Trial |
| 8,580,787 | Compositions and methods for reducing activation of alpha-1 receptors | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Bausch And Lomb Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Brazil | PI0418245 | ➤ Try a Free Trial |
| Japan | H10237070 | ➤ Try a Free Trial |
| Denmark | 0989972 | ➤ Try a Free Trial |
| Austria | 296093 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Bausch And Lomb Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0040 | Belgium | ➤ Try a Free Trial | PRODUCT NAME: ALATROFLOXACIN; NAT. REGISTRATION NO/DATE: EU/1/98/060/001 19980327; FIRST REGISTRATION: CH 54484 19980327 |
| C0111 | Belgium | ➤ Try a Free Trial | PRODUCT NAME: LATANOPROSTUM; NAT. REGISTRATION NO/DATE: 277 IS 271 F 13 19970617; FIRST REGISTRATION: SE 12716 1996071 |
| 90041 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: DORZOLAMIDE, DESGEWENST IN DE VORM VAN EEN OFTALMOLOGISCH AAN- VAARDBAAR ZOUT, EN TIMOLOL, DESGEWENST IN DE VORM VAN EEN OFTAL -MOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER DORZOLLAMIDEHY- DROCHLORIDE EN TIMOLOLMALEAAT, EEN EN ANDER ZODANIG DAT 0,05; NATL REGISTRATION NO/DATE: VG 22871 19980805; FIRST REGISTRATION: DK 19045 19980306 |
| C0031 | France | ➤ Try a Free Trial | PRODUCT NAME: BROMFENAC, SES SELS OU HYDRATES PHARMACOLOGIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/11/692/001 DU 20110518; REGISTRATION NO/DATE AT EEC: EU/1/11/692/001 DU 20110518 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
